Copyright
©The Author(s) 2021.
World J Gastrointest Oncol. Oct 15, 2021; 13(10): 1518-1531
Published online Oct 15, 2021. doi: 10.4251/wjgo.v13.i10.1518
Published online Oct 15, 2021. doi: 10.4251/wjgo.v13.i10.1518
Control (n = 5) | Control-P (n = 5) | DMH (n = 10) | DMH-C (n = 9) | DMH-P (n = 10) | DMH-C-P (n = 9) | |
Tumor1 | - | - | 10 (100) | 4 (44.5) | 10 (100.0) | 4 (44.5) |
Lung disease | - | - | - | 2 (22.2) | - | - |
Underweight | - | - | - | 1 (11.1) | - | 1 (11.0) |
ND | - | - | - | 2 (22.2) | - | 4 (44.5) |
Old age | 5 (100) | 5 (100) | - | - | - | - |
- Citation: Gigola G, Carriere P, Novoa Díaz MB, Perdigon G, Zwenger AO, Gentili C. Survival effect of probiotics in a rat model of colorectal cancer treated with capecitabine. World J Gastrointest Oncol 2021; 13(10): 1518-1531
- URL: https://www.wjgnet.com/1948-5204/full/v13/i10/1518.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v13.i10.1518